<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-162474" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Orthopedic and Podiatry Perioperative Antibiotics</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hayward</surname>
            <given-names>Dan</given-names>
          </name>
          <aff>LSU Health Shreveport</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nammour</surname>
            <given-names>Michael A.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dan Hayward declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Nammour declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>9</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-162474.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Perioperative antibiotics are crucial for achieving positive outcomes and preventing infections in orthopedic or podiatry surgery. These antibiotics are typically administered in the perioperative setting, which includes 3&#x000a0;phases&#x02014;preoperative, intraoperative, and postoperative.<xref ref-type="bibr" rid="article-162474.r1">[1]</xref>&#x000a0;The selection of specific antibiotic prophylaxis for each phase depends on various factors, including the nature of the surgery (elective or trauma), the type of fracture (open or closed), potential contaminants, and required bacterial coverage.&#x000a0;Surgeons must also consider relevant contraindications, such as prior allergic reactions and potential adverse effects.</p>
        <p>While nearly all elective orthopedic or podiatric surgery cases use perioperative antibiotics, a recent survey revealed a disparity in surgical antibiotic prophylaxis practices among surgeons.<xref ref-type="bibr" rid="article-162474.r2">[2]</xref>&#x000a0;In&#x000a0;non-arthroplasty cases, a dose of cefazolin is typically administered within 30 minutes before the first incision. Arthroplasty surgeons often augment this with preoperative vancomycin to counter methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA) infections. However, trauma cases necessitate a unique approach to antibiotic management due to the high variability of mechanisms of injury and the diverse types of wounds surrounding fractures, which leads to more complex algorithms for the choice of antibiotics.</p>
      </sec>
      <sec id="article-162474.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p><bold>Closed&#x000a0;Versus Open Fractures</bold>&#x000a0;</p>
        <p>In the trauma setting, each fracture requires assessment for skin compromise and is classified as either closed or open. Closed fractures do not violate the skin and are not subject to the same contamination risk as open fractures. Prophylaxis for closed fractures is typically sufficient with a first-generation cephalosporin, often cefazolin, administered before surgical incision and followed by 3 additional doses over the subsequent 24 hours postoperatively.</p>
        <p>Open fractures present a significant risk to limb integrity, and bacterial exposure may lead to osteomyelitis, nonunion, and potential amputation.<xref ref-type="bibr" rid="article-162474.r3">[3]</xref>&#x000a0;Gustilo and Anderson (GA)&#x000a0;introduced&#x000a0;a classification system to guide the treatment of open fractures. GA type I fractures involve open wounds of less than 1 cm. GA type II fractures feature open wounds ranging between 1&#x000a0;and 10 cm. GA type III fractures are divided into 3 subdivisions&#x02014;A, B, and C.&#x000a0;</p>
        <p>GA type IIIA fractures have open wounds larger than 10 cm or result from high-energy mechanisms of injury. GA type IIIB fractures require soft tissue flap rearrangement for wound coverage, whereas GA type IIIC fractures involve vascular injury. GA type IIIB or type IIIC fractures may be smaller than 10 cm but are still categorized as higher grades if the injury necessitates soft tissue coverage or involves vascular damage, respectively. Treatment for GA type III fractures typically involves a cephalosporin (such as cefazolin) or ceftriaxone and an aminoglycoside (such as gentamycin).&#x000a0;</p>
        <p><bold>Coverage Considerations</bold>&#x000a0;</p>
        <p>Surgical infections predominantly stem from bacterial sources, with fungal, parasitic, or viral etiologies being rare occurrences. Bacteria are classified as either gram-positive or gram-negative, with few exceptions. Antibiotic selection for postoperative infection prevention should be guided by the likely pathogens, primarily targeting gram-positive skin flora such as s&#x000a0;<italic toggle="yes">Staphylococcus aureus, S epidermidis, Streptococcus pyogenes, and S pneumoniae</italic>.<xref ref-type="bibr" rid="article-162474.r4">[4]</xref>&#x000a0;In shoulder surgery, consideration should also be given to the coverage of <italic toggle="yes">Cutibacterium acnes&#x000a0;</italic>(formerly known as&#x000a0;<italic toggle="yes">Propionibacterium acnes</italic>) should be considered.<xref ref-type="bibr" rid="article-162474.r5">[5]</xref><xref ref-type="bibr" rid="article-162474.r6">[6]</xref>&#x000a0;The most common antibiotics used perioperatively in orthopedic and podiatric surgery are cefazolin, ceftriaxone, vancomycin, clindamycin, penicillin, and ciprofloxacin.&#x000a0;</p>
        <p>In arthroplastic surgery, the combination of cefazolin and vancomycin is controversial. Initially, vancomycin prophylaxis was recommended in institutions with a high MRSA prevalence.<xref ref-type="bibr" rid="article-162474.r7">[7]</xref>&#x000a0;However, recent research indicates limited benefits and increased risks with the addition of vancomycin to cefazolin, particularly when it is not dosed correctly.<xref ref-type="bibr" rid="article-162474.r8">[8]</xref><xref ref-type="bibr" rid="article-162474.r9">[9]</xref><xref ref-type="bibr" rid="article-162474.r10">[10]</xref></p>
        <p>Open wounds contaminated with fresh water are susceptible to infection by <italic toggle="yes">Pseudomonas aeruginosa</italic>, a gram-negative rod. Such injuries necessitate additional antibiotic coverage with a fluoroquinolone, typically ciprofloxacin or levofloxacin.<xref ref-type="bibr" rid="article-162474.r11">[11]</xref>&#x000a0;In contrast, open wounds contaminated with salt water may be infected by various organisms, including vibrio species, and should be treated with doxycycline.<xref ref-type="bibr" rid="article-162474.r11">[11]</xref></p>
        <p>Open wounds resulting from farm injuries are frequently contaminated with barnyard soil or fecal matter, increasing the risk of infection with&#x000a0;<italic toggle="yes">Clostridium&#x000a0;</italic>species.&#x000a0;<italic toggle="yes">Clostridium&#x000a0;</italic>is a spore-forming organism that is effectively treated with a member of the penicillin family, often Penicillin G.<xref ref-type="bibr" rid="article-162474.r12">[12]</xref></p>
        <p>Aminoglycosides are used in the treatment of GA type III open injuries. Suzuki et al reported that gram-negative bacteria were isolated in 77% of GA type III injuries, underscoring the need for an effective agent with strong gram-negative coverage.<xref ref-type="bibr" rid="article-162474.r13">[13]</xref></p>
        <p>Vancomycin is indicated for use in individuals who are confirmed or potential carriers of MRSA.<xref ref-type="bibr" rid="article-162474.r9">[9]</xref></p>
        <p><bold>Allergy Considerations</bold>&#x000a0;</p>
        <p>Considering that cefazolin is the standard antibiotic prophylaxis for orthopedic and podiatric procedures, it is important to address patients with severe allergies to cefazolin. In such cases, clindamycin is frequently used as a secondary option due to its similar spectrum coverage.<xref ref-type="bibr" rid="article-162474.r14">[14]</xref></p>
        <p>Historically, cefazolin was avoided in patients with&#x000a0;beta-lactam&#x000a0;allergies due to cross-reactivity reported to be 8%.<xref ref-type="bibr" rid="article-162474.r15">[15]</xref>&#x000a0;However, more recent studies indicate a lower cross-reactivity rate of 0.7% and demonstrate fewer surgical site infections (SSIs) in patients with a documented penicillin allergy who received cefazolin compared to alternatives such as clindamycin or vancomycin.<xref ref-type="bibr" rid="article-162474.r16">[16]</xref><xref ref-type="bibr" rid="article-162474.r17">[17]</xref> Patients with proven or possible MRSA colonization who exhibit an allergy to vancomycin should receive treatment with alternative antibiotics such as daptomycin, tigecycline, or linezolid.<xref ref-type="bibr" rid="article-162474.r18">[18]</xref></p>
        <p><bold>Adverse Effects</bold>&#x000a0;</p>
        <p>All antibiotics routinely used for perioperative prophylaxis in orthopedic and podiatric surgery may lead to mild adverse effects, including gastrointestinal upset. However, judicial selection of antibiotics is essential when there is a risk of life-threatening or organ-damaging effects. Cefazolin has the potential to induce anaphylaxis, while ceftriaxone may lead to anaphylaxis and hematemesis. Vancomycin is associated with red man syndrome and nephrotoxicity.<xref ref-type="bibr" rid="article-162474.r19">[19]</xref>&#x000a0;Clindamycin may cause pseudomembranous colitis.<xref ref-type="bibr" rid="article-162474.r20">[20]</xref><xref ref-type="bibr" rid="article-162474.r21">[21]</xref>&#x000a0;Penicillin may result in adverse reactions such as hives, laryngospasm, and anaphylaxis in hypersensitive patients.<xref ref-type="bibr" rid="article-162474.r22">[22]</xref>&#x000a0;Gentamicin carries risks of nephrotoxicity, tinnitus, and vestibular dysfunction.<xref ref-type="bibr" rid="article-162474.r23">[23]</xref>&#x000a0;Fluoroquinolones have been documented to increase the risk of tendon rupture and cause arrhythmias.<xref ref-type="bibr" rid="article-162474.r24">[24]</xref><xref ref-type="bibr" rid="article-162474.r25">[25]</xref></p>
        <p><bold>Mechanism of Action</bold>&#x000a0;</p>
        <p><bold>Cefazolin:</bold> Cefazolin, belonging to the first-generation cephalosporin family, functions by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, consequently leading to cell lysis. The drug exhibits effectiveness against gram-positive bacteria, notably <italic toggle="yes">S aureus</italic>, group A <italic toggle="yes">Streptococcus</italic>, and <italic toggle="yes">S pneumoniae</italic>.<xref ref-type="bibr" rid="article-162474.r26">[26]</xref></p>
        <p><bold>Ceftriaxone:</bold>&#x000a0;Ceftriaxone belongs to the&#x000a0;third-generation cephalosporin family that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, ultimately leading to cell lysis. The spectrum of ceftriaxone is much broader than that of cefazolin and other first-generation cephalosporins, thus targeting both gram-positive and gram-negative bacteria.</p>
        <p><bold>Vancomycin:</bold> Vancomycin exhibits bacteriostatic activity by binding&#x000a0;the D-ala-D-ala protein in the bacterial cell wall. This drug is effective against gram-positive bacteria and is the first-line treatment for MRSA infections.<xref ref-type="bibr" rid="article-162474.r9">[9]</xref></p>
        <p><bold>Clindamycin:</bold>&#x000a0;Clindamycin is classified as a lincosamide, and it functions by binding to the 23S RNA of the 50s ribosomal subunit, thereby inhibiting protein synthesis and exerting bacteriostatic activity. This drug is notably effective against gram-positive bacteria, including staphylococci and streptococci, as well as anaerobic bacteria, including <italic toggle="yes">Bacteroides</italic> species.<xref ref-type="bibr" rid="article-162474.r27">[27]</xref>&#x000a0;However, it does not provide coverage against MRSA or gram-negative bacteria.<xref ref-type="bibr" rid="article-162474.r28">[28]</xref></p>
        <p><bold>Gentamycin:</bold> Gentamycin is a member of the aminoglycoside family, and it functions&#x000a0;by binding to the 16S RNA of the 30s ribosome, causing mistranslation of polypeptide chains and eventual cell death.<xref ref-type="bibr" rid="article-162474.r29">[29]</xref>&#x000a0;Aminoglycosides are recognized for their broad-spectrum activity, covering gram-positive and gram-negative bacteria, as well as mycobacteria.&#x000a0;</p>
        <p><bold>Penicillin:</bold> Penicillins are a family of&#x000a0;bactericidal agents that function by binding to penicillin-binding proteins, thereby inhibiting cell wall synthesis. They demonstrate efficacy against gram-positive bacteria, including <italic toggle="yes">Clostridium</italic> species, but have limited effectiveness against gram-negative bacteria and are ineffective against organisms producing beta-lactamases.&#x000a0;</p>
        <p><bold>Ciprofloxacin:</bold>&#x000a0;Ciprofloxacin is a member of the fluoroquinolone family. This drug inhibits the function of DNA gyrase and DNA topoisomerase, leading to DNA synthesis inhibition and bacteriolysis. The drug is effective against gram-negative bacteria, particularly&#x000a0;<italic toggle="yes">P aeruginosa</italic>&#x000a0;and&#x000a0;<italic toggle="yes">E coli</italic>.&#x000a0;</p>
        <p><bold>Timing</bold>&#x000a0;</p>
        <p>The current guidelines recommend administering surgical antibiotic prophylaxis within 60 minutes before the surgical incision or within 120 minutes for antibiotics requiring slower infusion times, such as vancomycin.<xref ref-type="bibr" rid="article-162474.r30">[30]</xref><xref ref-type="bibr" rid="article-162474.r31">[31]</xref>&#x000a0;A part of the Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) study assessed the effects of antibiotics administered within specific 30-minute increments around the time of hip and knee replacement surgeries. The study revealed that the lowest rates of SSIs were observed when the antibiotic was administered within a 30-minute window before the skin incision.<xref ref-type="bibr" rid="article-162474.r32">[32]</xref>&#x000a0;Postoperatively, antibiotics should be continued for no more than 24 hours in elective cases where the patient remains under observation or inpatient care, such as during evaluation by a physical therapist. Notably, it is crucial to adhere to dosing guidelines to maintain appropriate pharmacokinetics, for instance, administering cefazolin 2 g intravenously (IV) every 8 hours.</p>
        <p>The use of postoperative oral antibiotics in the outpatient setting is controversial, with limited available data. Currently, standardized recommendations for oral antibiotics do not exist in the current literature. Frederick et al discovered no statistically significant difference in patients undergoing foot and ankle surgery who did or did not receive postoperative oral antibiotics.<xref ref-type="bibr" rid="article-162474.r33">[33]</xref>&#x000a0;Conversely, DeFrancesco et al observed that high-risk patients experienced benefits from 1 week of extended oral antibiotics, resulting in reduced rates of prosthetic joint infections.<xref ref-type="bibr" rid="article-162474.r34">[34]</xref>&#x000a0;Future randomized controlled trials may provide further clarity on the subject of oral antibiotics following outpatient surgery.</p>
        <p>In the trauma setting, special consideration is given to antibiotic administration timing, necessitating a fourth phase termed "post-injury" dose, administered after the presentation but before initiating pre-operative protocols. The literature shows that administering antibiotics within 1 hour of the injury yields superior outcomes compared to delayed treatment.<xref ref-type="bibr" rid="article-162474.r35">[35]</xref><xref ref-type="bibr" rid="article-162474.r36">[36]</xref>&#x000a0;Furthermore, perioperative antibiotic administration should adhere to a schedule based on the timing of the initial dose. GA type I and type II injuries necessitate perioperative prophylaxis for 24 hours, while GA type III injuries require antibiotic administration for 72 hours during the postoperative period.</p>
        <p>The frequency of administration for each antibiotic is determined by its half-life. Cefazolin, with a half-life of 1.8 hours, is administered every 8 hours. Ceftriaxone, with a reported half-life between 5.8 and 8.7 hours, is given every 24 hours. Vancomycin, with a bi-phasic half-life, has an initial half-life and a terminal half-life of 6 hours and is administered every 8 hours. Clindamycin, with a half-life of 2.4 hours, is administered every 8 hours. Gentamicin, with a half-life of 3 hours, is administered every 8 hours. Penicillin G, with a reported half-life of 30 to 60 minutes, is administered every 4 to 6 hours. Ciprofloxacin, with a half-life of 5 hours, is administered every 12 hours.&#x000a0;</p>
        <p>
<bold>Available Dosages</bold>
</p>
        <p>IV administration is the preferred method for all antibiotics during the perioperative period. Dosing guidelines for adult patients are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cefazolin is dosed at 1 g for patients with a body weight of less than 60 kg, 2 g for patients with a body weight of 60 to 120 kg, and 3 g for patients with a body weight of more than 120 kg.<xref ref-type="bibr" rid="article-162474.r37">[37]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Ceftriaxone is dosed at 2 g.<xref ref-type="bibr" rid="article-162474.r38">[38]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Vancomycin is dosed at 15 to 20 mg/kg.<xref ref-type="bibr" rid="article-162474.r19">[19]</xref>&#x000a0;Pharmacists make dosage adjustments, and serum trough levels are typically monitored.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Clindamycin is dosed at 600 mg for patients with a body weight of less than 75 kg and 900 mg for&#x000a0;patients with a body weight of more than 75 kg.<xref ref-type="bibr" rid="article-162474.r39">[39]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>IV penicillin G&#x000a0;is dosed at 2 million units for surgical prophylaxis.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Gentamicin&#x000a0;is dosed at 6 mg/kg.<xref ref-type="bibr" rid="article-162474.r40">[40]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>IV ciprofloxacin is dosed at 400 mg.<xref ref-type="bibr" rid="article-162474.r41">[41]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>When tailoring antibiotic prophylaxis for the pediatric population, accurate dosing is essential, utilizing the patient's age, weight, and body mass index (BMI) according to the manufacturer's dosing schedule.</p>
      </sec>
      <sec id="article-162474.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Orthopedic and podiatric surgeries, particularly those involving implanted metal hardware, are at risk for SSIs. The reported annual incidence of SSIs ranges from 1.9% to 3.6% in orthopedic surgery and 3.4% to 4.2% in podiatric foot and ankle surgery.<xref ref-type="bibr" rid="article-162474.r42">[42]</xref><xref ref-type="bibr" rid="article-162474.r43">[43]</xref><xref ref-type="bibr" rid="article-162474.r44">[44]</xref>&#x000a0;Long-term complications of SSIs include prolonged morbidity, disability, and increased mortality. SSIs are the primary cause of unplanned hospital readmissions among surgical patients.<xref ref-type="bibr" rid="article-162474.r45">[45]</xref> Prophylactic antibiotic use has become a standard practice to mitigate the risk of SSIs and their associated complications.<xref ref-type="bibr" rid="article-162474.r14">[14]</xref><xref ref-type="bibr" rid="article-162474.r2">[2]</xref>&#x000a0;</p>
        <p>Patients undergoing arthroplasty are susceptible to prosthetic joint infection, with reported incidence rates ranging from 0.1% to 11.1% of cases. Prosthetic joint infection can lead to subsequent surgeries, reduced quality of life, amputation, permanent disability, and increased mortality.<xref ref-type="bibr" rid="article-162474.r46">[46]</xref><xref ref-type="bibr" rid="article-162474.r47">[47]</xref>&#x000a0;Often, vancomycin is administered in the preoperative phase to mitigate the risk of prosthetic joint infection secondary to&#x000a0;<italic toggle="yes">S aureus</italic>.</p>
        <p>Although prophylactic antibiotic administration is crucial to safe surgical practice, it poses inherent risks to patients. Systemic&#x000a0;antibiotic use may disrupt the gut microbiota and cause severe cutaneous adverse reactions, opportunistic infections,&#x000a0;or allergic reactions.<xref ref-type="bibr" rid="article-162474.r22">[22]</xref><xref ref-type="bibr" rid="article-162474.r48">[48]</xref>&#x000a0;Furthermore, overuse of antibiotics may lead to the emergence of multidrug-resistant organisms, with potentially devastating consequences.<xref ref-type="bibr" rid="article-162474.r49">[49]</xref>&#x000a0;Therefore, it is crucial to carefully select and administer appropriate perioperative antibiotics for orthopedic or podiatric patients to mitigate the risk of surgical site infections or prosthetic joint infections while minimizing adverse reactions and preventing the proliferation of multidrug-resistant organisms. Antibiotic stewardship is a collective responsibility shared by all healthcare team members.</p>
      </sec>
      <sec id="article-162474.s4" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients undergoing orthopedic or podiatric surgery face the risk of SSIs, which can be mitigated through perioperative antibiotic prophylaxis spanning the preoperative, intraoperative, and postoperative phases. Tailored antibiotic coverage is necessary for specific scenarios, such as vancomycin for MRSA carriers, penicillin for contamination with barnyard soil, and clindamycin for patients with cefazolin allergies. Ensuring the indicated antibiotics are administered via the correct route, at the proper dosage, and within the appropriate timing is essential.</p>
        <p>Effective perioperative antibiotic prophylaxis relies on consistent practice and collaboration among an integrated healthcare team. This team typically includes primary surgeons, surgical assistants, anesthesia personnel, surgical technicians, circulating nurses, floor nurses, pharmacists, advanced practitioners, and any other clinicians involved in the patient&#x02019;s care. Each member of the team plays a crucial role in ensuring appropriate prophylaxis and its timing, mitigating adverse events related to allergies or toxicity, and optimizing patient outcomes. Collaboration among these diverse healthcare professionals is essential for successful perioperative antibiotic management.</p>
      </sec>
      <sec id="article-162474.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=162474&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=162474">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/162474/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=162474">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-162474.s6">
        <title>References</title>
        <ref id="article-162474.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davrieux</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Palermo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Serra</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Houghton</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Acquafresca</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Finger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gim&#x000e9;nez</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>STAGES AND FACTORS OF THE "PERIOPERATIVE PROCESS": POINTS IN COMMON WITH THE AERONAUTICAL INDUSTRY.</article-title>
            <source>Arq Bras Cir Dig</source>
            <year>2019</year>
            <month>Feb</month>
            <day>07</day>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>e1423</fpage>
            <pub-id pub-id-type="pmid">30758471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santoshi</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Behera</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nagar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Current Surgical Antibiotic Prophylaxis Practices: A Survey of Orthopaedic Surgeons in India.</article-title>
            <source>Indian J Orthop</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>55</volume>
            <issue>3</issue>
            <fpage>749</fpage>
            <page-range>749-757</page-range>
            <pub-id pub-id-type="pmid">33995883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masters</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Trombetta</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>de Mesy Bentley</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Nishitani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bello-Irizarry</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Ninomiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brodell</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Hao</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Daiss</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Kates</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Muthukrishnan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Evolving concepts in bone infection: redefining "biofilm", "acute vs. chronic osteomyelitis", "the immune proteome" and "local antibiotic therapy".</article-title>
            <source>Bone Res</source>
            <year>2019</year>
            <volume>7</volume>
            <fpage>20</fpage>
            <pub-id pub-id-type="pmid">31646012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Kheir</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Maltenfort</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Should Preoperative Antibiotics Be Tailored According to Patient's Comorbidities and Susceptibility to Organisms?</article-title>
            <source>J Arthroplasty</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>1089</fpage>
            <page-range>1089-1094.e3</page-range>
            <pub-id pub-id-type="pmid">28040397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boyanova</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title><italic>Cutibacterium acnes</italic> (formerly <italic>Propionibacterium acnes</italic>): friend or foe?</article-title>
            <source>Future Microbiol</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>18</volume>
            <fpage>235</fpage>
            <page-range>235-244</page-range>
            <pub-id pub-id-type="pmid">37042433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Gregori</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Horneff</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Namdari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lazarus</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Cutibacterium acnes: a threat to shoulder surgery or an orthopedic red herring?</article-title>
            <source>J Shoulder Elbow Surg</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>9</issue>
            <fpage>1920</fpage>
            <page-range>1920-1927</page-range>
            <pub-id pub-id-type="pmid">32499199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bratzler</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Houck</surname>
                <given-names>PM</given-names>
              </name>
              <collab>Surgical Infection Prevention Guidelines Writers Workgroup</collab>
              <collab>American Academy of Orthopaedic Surgeons</collab>
              <collab>American Association of Critical Care Nurses</collab>
              <collab>American Association of Nurse Anesthetists</collab>
              <collab>American College of Surgeons</collab>
              <collab>American College of Osteopathic Surgeons</collab>
              <collab>American Geriatrics Society</collab>
              <collab>American Society of Anesthesiologists</collab>
              <collab>American Society of Colon and Rectal Surgeons</collab>
              <collab>American Society of Health-System Pharmacists</collab>
              <collab>American Society of PeriAnesthesia Nurses</collab>
              <collab>Ascension Health</collab>
              <collab>Association of periOperative Registered Nurses</collab>
              <collab>Association for Professionals in Infection Control and Epidemiology</collab>
              <collab>Infectious Diseases Society of America</collab>
              <collab>Medical Letter</collab>
              <collab>Premier</collab>
              <collab>Society for Healthcare Epidemiology of America</collab>
              <collab>Society of Thoracic Surgeons</collab>
              <collab>Surgical Infection Society</collab>
            </person-group>
            <article-title>Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project.</article-title>
            <source>Clin Infect Dis</source>
            <year>2004</year>
            <month>Jun</month>
            <day>15</day>
            <volume>38</volume>
            <issue>12</issue>
            <fpage>1706</fpage>
            <page-range>1706-15</page-range>
            <pub-id pub-id-type="pmid">15227616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peel</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Astbury</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Paterson</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Buising</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Spelman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tran-Duy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Adie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McDougall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Molnar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mulford</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rehfisch</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harris-Brown</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Roney</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wisniewski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de Steiger</surname>
                <given-names>R</given-names>
              </name>
              <collab>ASAP Trial Group</collab>
            </person-group>
            <article-title>Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty.</article-title>
            <source>N Engl J Med</source>
            <year>2023</year>
            <month>Oct</month>
            <day>19</day>
            <volume>389</volume>
            <issue>16</issue>
            <fpage>1488</fpage>
            <page-range>1488-1498</page-range>
            <pub-id pub-id-type="pmid">37851875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kheir</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Azboy</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Parvizi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>475</volume>
            <issue>7</issue>
            <fpage>1767</fpage>
            <page-range>1767-1774</page-range>
            <pub-id pub-id-type="pmid">28401341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choe</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Koo</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bae</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Bang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence.</article-title>
            <source>BMC Infect Dis</source>
            <year>2018</year>
            <month>Apr</month>
            <day>16</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>178</fpage>
            <pub-id pub-id-type="pmid">29661158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noonburg</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Management of extremity trauma and related infections occurring in the aquatic environment.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2005</year>
            <season>Jul-Aug</season>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>243</fpage>
            <page-range>243-53</page-range>
            <pub-id pub-id-type="pmid">16112981</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dornbusch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nord</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Dahlb&#x000e4;ck</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic susceptibility of Clostridium species isolated from human infections.</article-title>
            <source>Scand J Infect Dis</source>
            <year>1975</year>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-34</page-range>
            <pub-id pub-id-type="pmid">170668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kurozumi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Type III Gustilo-Anderson open fracture does not justify routine prophylactic Gram-negative antibiotic coverage.</article-title>
            <source>Sci Rep</source>
            <year>2023</year>
            <month>May</month>
            <day>01</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>7085</fpage>
            <pub-id pub-id-type="pmid">37127796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhammi</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Ul Haq</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Prophylactic antibiotics in orthopedic surgery: Controversial issues in its use.</article-title>
            <source>Indian J Orthop</source>
            <year>2015</year>
            <season>Jul-Aug</season>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>373</fpage>
            <page-range>373-6</page-range>
            <pub-id pub-id-type="pmid">26229155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sousa-Pinto</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blumenthal</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Courtney</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Jeffres</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Assessment of the Frequency of Dual Allergy to Penicillins and Cefazolin: A Systematic Review and Meta-analysis.</article-title>
            <source>JAMA Surg</source>
            <year>2021</year>
            <month>Apr</month>
            <day>01</day>
            <volume>156</volume>
            <issue>4</issue>
            <fpage>e210021</fpage>
            <pub-id pub-id-type="pmid">33729459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarfani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Understanding Penicillin Allergy, Cross-reactivity, and Antibiotic Selection in the Preoperative Setting.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2022</year>
            <month>Jan</month>
            <day>01</day>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>e1</fpage>
            <page-range>e1-e5</page-range>
            <pub-id pub-id-type="pmid">34669610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norvell</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ricco</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Koonce</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Basler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jeffres</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Cefazolin vs Second-line Antibiotics for Surgical Site Infection Prevention After Total Joint Arthroplasty Among Patients With a Beta-lactam Allergy.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>ofad224</fpage>
            <pub-id pub-id-type="pmid">37363051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Micek</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.</article-title>
            <source>Clin Infect Dis</source>
            <year>2007</year>
            <month>Sep</month>
            <day>15</day>
            <volume>45 Suppl 3</volume>
            <fpage>S184</fpage>
            <page-range>S184-90</page-range>
            <pub-id pub-id-type="pmid">17712745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elbarbry</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice.</article-title>
            <source>Eur J Drug Metab Pharmacokinet</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>259</fpage>
            <page-range>259-268</page-range>
            <pub-id pub-id-type="pmid">29260505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smieja</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Current indications for the use of clindamycin: A critical review.</article-title>
            <source>Can J Infect Dis</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-8</page-range>
            <pub-id pub-id-type="pmid">22346533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amin</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic-associated pseudomembranous colitis.</article-title>
            <source>Am Fam Physician</source>
            <year>1985</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>115</fpage>
            <page-range>115-20</page-range>
            <pub-id pub-id-type="pmid">3993509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohsen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dickinson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Somayaji</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Update on the adverse effects of antimicrobial therapies in community practice.</article-title>
            <source>Can Fam Physician</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>66</volume>
            <issue>9</issue>
            <fpage>651</fpage>
            <page-range>651-659</page-range>
            <pub-id pub-id-type="pmid">32933978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kahlmeter</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dahlager</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>1984</year>
            <month>Jan</month>
            <volume>13 Suppl A</volume>
            <fpage>9</fpage>
            <page-range>9-22</page-range>
            <pub-id pub-id-type="pmid">6365884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huser</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Association between tendon ruptures and use of fluoroquinolone, and other oral antibiotics: a 10-year retrospective study of 1 million US senior Medicare beneficiaries.</article-title>
            <source>BMJ Open</source>
            <year>2020</year>
            <month>Dec</month>
            <day>21</day>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>e034844</fpage>
            <pub-id pub-id-type="pmid">33371012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aspinall</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Sylvain</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Echevarria</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Glassman</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Goetz</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self-controlled case series analysis.</article-title>
            <source>Pharmacol Res Perspect</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>e00664</fpage>
            <pub-id pub-id-type="pmid">33047487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmitz</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Rubino</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Onufrak</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Licursi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Karpf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cetnarowski</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics and Optimal Dose Selection of Cefazolin for Surgical Prophylaxis of Pediatric Patients.</article-title>
            <source>J Clin Pharmacol</source>
            <year>2021</year>
            <month>May</month>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>666</fpage>
            <page-range>666-676</page-range>
            <pub-id pub-id-type="pmid">33202066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nodzo</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Frisch</surname>
                <given-names>NB</given-names>
              </name>
            </person-group>
            <article-title>Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?</article-title>
            <source>J Arthroplasty</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>7S</issue>
            <fpage>S302</fpage>
            <page-range>S302-S306</page-range>
            <pub-id pub-id-type="pmid">30745218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosco</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bookman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Slover</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Edusei</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Principles of Antibiotic Prophylaxis in Total Joint Arthroplasty: Current Concepts.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>8</issue>
            <fpage>e27</fpage>
            <page-range>e27-35</page-range>
            <pub-id pub-id-type="pmid">26209148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krause</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Serio</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Aminoglycosides: An Overview.</article-title>
            <source>Cold Spring Harb Perspect Med</source>
            <year>2016</year>
            <month>Jun</month>
            <day>01</day>
            <volume>6</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">27252397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baseel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mohammed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siddiqi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The Ideal Time to Administer Pre-operative Antibiotics: Current and Future Practices.</article-title>
            <source>Cureus</source>
            <year>2022</year>
            <month>May</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>e24979</fpage>
            <pub-id pub-id-type="pmid">35719787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Jonge</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Gans</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Atema</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Solomkin</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Dellinger</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Boermeester</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Timing of preoperative antibiotic prophylaxis in 54,552 patients and the risk of surgical site infection: A systematic review and meta-analysis.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>96</volume>
            <issue>29</issue>
            <fpage>e6903</fpage>
            <pub-id pub-id-type="pmid">28723736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinberg</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Hellinger</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Kusek</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bozikis</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Bush</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Dellinger</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kritchevsky</surname>
                <given-names>SB</given-names>
              </name>
              <collab>Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) Study Group</collab>
            </person-group>
            <article-title>Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors.</article-title>
            <source>Ann Surg</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>250</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-6</page-range>
            <pub-id pub-id-type="pmid">19561486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frederick</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Burnette</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Joyce</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Bettin</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Grear</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of Postoperative Oral Antibiotics in Foot and Ankle Surgery.</article-title>
            <source>Foot Ankle Int</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>43</volume>
            <issue>9</issue>
            <fpage>1204</fpage>
            <page-range>1204-1210</page-range>
            <pub-id pub-id-type="pmid">35778868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeFrancesco</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Kahlenberg</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Bostrom</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Extended Antibiotic Prophylaxis May Be Linked to Lower Peri-prosthetic Joint Infection Rates in High-Risk Patients: An Evidence-Based Review.</article-title>
            <source>HSS J</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>297</fpage>
            <page-range>297-301</page-range>
            <pub-id pub-id-type="pmid">31624486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliphant</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Jakubus</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Mikhail</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Sangji</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Hemmila</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Decreasing time to antibiotic administration in open fractures of the femur and tibia through performance improvement in a statewide trauma: Collaborative quality initiative.</article-title>
            <source>Surgery</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>171</volume>
            <issue>3</issue>
            <fpage>777</fpage>
            <page-range>777-784</page-range>
            <pub-id pub-id-type="pmid">34876285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harper</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Eccles</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rehman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Administration of intravenous antibiotics in patients with open fractures is dependent on emergency room triaging.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>e0202013</fpage>
            <pub-id pub-id-type="pmid">30106964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mohayya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Modi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abdul Azim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Brunetti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Narayanan</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Safety and Effectiveness of High-Dose Cefazolin in Patients With High Body Weight: A Retrospective Cohort Study.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>ofac105</fpage>
            <pub-id pub-id-type="pmid">35350175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ayele</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Gebresillassie</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Erku</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Gebreyohannes</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Demssie</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Mersha</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Tegegn</surname>
                <given-names>HG</given-names>
              </name>
            </person-group>
            <article-title>Prospective evaluation of Ceftriaxone use in medical and emergency wards of Gondar university referral hospital, Ethiopia.</article-title>
            <source>Pharmacol Res Perspect</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>6</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29417764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouazza</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pestre</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Jullien</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Curis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Urien</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Salmon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tr&#x000e9;luyer</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>74</volume>
            <issue>6</issue>
            <fpage>971</fpage>
            <page-range>971-7</page-range>
            <pub-id pub-id-type="pmid">22486719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Russell</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Pearsall</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Once daily high-dose gentamicin to prevent infection in open fractures of the tibial shaft: a preliminary investigation.</article-title>
            <source>South Med J</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>94</volume>
            <issue>12</issue>
            <fpage>1185</fpage>
            <page-range>1185-91</page-range>
            <pub-id pub-id-type="pmid">11811857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Markham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Balfour</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.</article-title>
            <source>Drugs</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>1019</fpage>
            <page-range>1019-74</page-range>
            <pub-id pub-id-type="pmid">8736621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Mulhim</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Baragbah</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sadat-Ali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alomran</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Azam</surname>
                <given-names>MQ</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of surgical site infection in orthopedic surgery: a 5-year analysis.</article-title>
            <source>Int Surg</source>
            <year>2014</year>
            <season>May-Jun</season>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>264</fpage>
            <page-range>264-8</page-range>
            <pub-id pub-id-type="pmid">24833150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mosleh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baradaranfard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jokar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akbari</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Aarabi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of surgical site infection after orthopaedic surgery with two types of drainage at three public hospitals in Iran.</article-title>
            <source>Int J Orthop Trauma Nurs</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>43</volume>
            <fpage>100842</fpage>
            <pub-id pub-id-type="pmid">34049832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Asadi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Farzan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of surgical site infection and risk factors in patients after foot and ankle surgery: A systematic review and meta-analysis.</article-title>
            <source>Int Wound J</source>
            <year>2024</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>e14350</fpage>
            <pub-id pub-id-type="pmid">37606302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Merkow</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Ju</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Bilimoria</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <article-title>Underlying reasons associated with hospital readmission following surgery in the United States.</article-title>
            <source>JAMA</source>
            <year>2015</year>
            <month>Feb</month>
            <day>03</day>
            <volume>313</volume>
            <issue>5</issue>
            <fpage>483</fpage>
            <page-range>483-95</page-range>
            <pub-id pub-id-type="pmid">25647204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wildeman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rolfson</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>S&#x000f6;derquist</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wretenberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lindgren</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>What Are the Long-term Outcomes of Mortality, Quality of Life, and Hip Function after Prosthetic Joint Infection of the Hip? A 10-year Follow-up from Sweden.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>2021</year>
            <month>Oct</month>
            <day>01</day>
            <volume>479</volume>
            <issue>10</issue>
            <fpage>2203</fpage>
            <page-range>2203-2213</page-range>
            <pub-id pub-id-type="pmid">34061486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindeque</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hartman</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Noshchenko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cruse</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Infection after primary total hip arthroplasty.</article-title>
            <source>Orthopedics</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>257</fpage>
            <page-range>257-65</page-range>
            <pub-id pub-id-type="pmid">24762833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Sindy</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Rosaline Hui</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Severe cutaneous adverse reactions related to systemic antibiotics.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>May</month>
            <volume>58</volume>
            <issue>10</issue>
            <fpage>1377</fpage>
            <page-range>1377-85</page-range>
            <pub-id pub-id-type="pmid">24599767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-162474.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reitan</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>McBroom</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Gilder</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>The Risk of Infection and Indication of Systemic Antibiotics in Chronic Wounds.</article-title>
            <source>Wounds</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>7</issue>
            <fpage>186</fpage>
            <page-range>186-194</page-range>
            <pub-id pub-id-type="pmid">33166266</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
